Shares of US protein-based vaccine maker Novavax closed down 19.4% at $10.15 yesterday having dropped as much as 24%, on the ...

Chengdu Baiyu Pharmaceutical yesterday announced that it has entered into an exclusive license agreement with Swiss pharma ...

Gan & Lee Pharmaceuticals (SHE: 603087) reported positive Phase II trial results for its diabetes drugs GZR18, GZR4, and ...

University Medical Center Groningen and SHINE Europe have secured an €10.5 million ($11 million) grant to boost European ...

The rocky road goes on for Intercept Pharmaceuticals with its primary biliary cholangitis (PBC) candidate Ocaliva ...

The US Food and Drug Administration (FDA) has updated the US label for French pharma major Sanofi’s Flublok (Influenza ...

RNA specialist Wave Life Sciences has been told by Takeda that the Japanese drugmaker is to bring to an end the last facet of ...

The chronic obstructive pulmonary disease (COPD) market in the seven major markets (7MM) is set to grow from $11.5 billion in ...

A new NIH clinical trial shows the Jynneos (MVA-BN) vaccine is safe for adolescents and produces an antibody response similar ...

Sanofi has partnered with Orano Med, a subsidiary of Orano Group, to develop radioligand therapies for rare cancers. Sanofi ...

The US Food and Drug Administration (FDA) yesterday published the guidance for industry, “Requests for Reconsideration at the ...

US RNA medicines biotech Wave Life Sciences yesterday announced positive proof-of-mechanism data from the ongoing Phase ...